Chemotype Balanced 1 1
Chemotype Balanced 1:1 refers to cannabis cultivars with roughly equal concentrations of THC and CBD, typically in ratios approximating 1:1 by dry weight. This chemotype emerged as breeders selectively crossed high-CBD and high-THC parent lines to stabilize intermediate cannabinoid profiles. Lineage records frequently report that stabilizing 1:1 ratios requires multiple generations of targeted selection, as cannabinoid expression is polygenic and environmentally influenced. The category is primarily of breeding and research interest, as achieving stable 1:1 offspring from such crosses remains genetically challenging. This chemotype family includes both indica-dominant and sativa-dominant genetic backgrounds, depending on the parent material used.
Chemotype Balanced 1 1 strains
No strains tagged into Chemotype Balanced 1 1 yet — they'll appear here as breeders submit lineage records under this family.
Chemotype Balanced 1:1 refers to cannabis cultivars with roughly equal concentrations of THC and CBD, typically in ratios approximating 1:1 by dry weight. This chemotype emerged as breeders selectively crossed high-CBD and high-THC parent lines to stabilize intermediate cannabinoid profiles. Lineage records frequently report that stabilizing 1:1 ratios requires multiple generations of targeted selection, as cannabinoid expression is polygenic and environmentally influenced. The category is primarily of breeding and research interest, as achieving stable 1:1 offspring from such crosses remains genetically challenging. This chemotype family includes both indica-dominant and sativa-dominant genetic backgrounds, depending on the parent material used.
Breeders working in this category use 1:1 cultivars as bridge parents to develop cannabinoid-specific lines and to map quantitative trait loci (QTL) controlling THC and CBD synthesis. Stable 1:1 chemotype lines serve as reference materials for understanding how cannabinoid ratios segregate across generations.
Educational reference · Cultivar metadata only · No medical claims